Loading
Latest filing published 26 Jan 2026 for LAKEFRONT BIOTHERAPEUTICS, €11k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Griffiths Jane appears in our data through filings on Lakefront Biotherapeutics shares, published by FSMA. The record holds 3 filings, all for trades on 22 January 2026.
No open-market sale appears; the market trades are 3 purchases worth €33k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Half of the purchases are above €11k and half below.
Most recently, on 26 January 2026, the filings show an open-market purchase worth €11k in Lakefront Biotherapeutics. Filings reach the FSMA feed a median of 4 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from FSMA. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration